|Articles|January 14, 2009
Unilateral Avastin to treat diffuse DME
THE EFFECT OF UNILATERAL INTRAVITREAL BEVACIZUMAB (AVASTIN), IN THE TREATMENT OF DIFFUSE BILATERAL DIABETIC MACULAR EDEMA: A PILOT STUDY.
Advertisement
THE EFFECT OF UNILATERAL INTRAVITREAL BEVACIZUMAB (AVASTIN), IN THE TREATMENT OF DIFFUSE BILATERAL DIABETIC MACULAR EDEMA: A PILOT STUDY. From the journal Retina.
Please click
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
3
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















